Embed Size (px)
DESCRIPTION
Presentation held by Thomas Lund, CEO of Advalight, at the Nordic Seed Capital Summit 2011 in Stockholm on 19 May 2011.
Citation preview
www.advalight.com
Investment opportunity:
Unique yellow laser technology for medical applications
Stockholm, Sweden, May 19, 2011
By Thomas Lund, CEO
PERSPECTIVE
Niels Finsen, MD (1860-1904) Nobel Prize in Physiology or Medicine 1903
”treatment of skin diseases using concentrated sun light”
Source: http://nobelprize.org/nobel_prizes/lists/year/?year=1903
ADVALIGHT
Morten Thorhauge, Ph.D. Danish Optical Society Award 2010
”Yellow laser technology for medical applications”
Photos cou
rtesy of Ellipse
TODAY -‐ DERMATOLOGY
PROTOTYPE
MARKET IMPERFECTION
KEY OPINION LEADERS
END-‐CUSTOMER VALUE & COMPETING TECHNOLOGIES
Competitive position in the vascular area
Clin
ical eff
icacy
Cost efficacy d
Low High
Hig
h
Low
Green solid-state
Advalight solid-state Dye
IPL
THE NUMBERS
US$ 12m revenue
Match
2014 exit
US$ 750m market 15-20% CAGR
US$ 3m investment
PATENTS
WO/2008/006371 EP 09 17 3000
PA 2010 00304 DE 19794175
